Effects of exogenous growth hormone on resting pulmonary function in children with thermal injury

Oscar E Suman1, Ronald P Mlcak, David N Herndon

  • 1Medical Staff Administration, Shriners Hospitals for Children and Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77550, USA.

Insights

Growth hormone (GH) therapy did not significantly improve pulmonary function (PF) in burned children over one year. While PF improved in both treated and placebo groups, GH offered no additional benefit for these children recovering from severe burns.

Area of Science:

  • Pediatric Burn Recovery
  • Pulmonary Medicine
  • Endocrinology

Background:

  • Burn-injured children often experience long-term pulmonary function (PF) deficits.
  • Growth hormone (GH) therapy has shown promise in improving PF in conditions like cystic fibrosis.
  • The efficacy of GH for PF improvement in pediatric burn survivors remains unestablished.

Purpose of the Study:

  • To investigate the impact of GH administration on pulmonary function in children with severe burn injuries.
  • To determine if GH therapy can enhance lung function recovery in pediatric burn survivors.

Main Methods:

  • A randomized controlled trial involving 30 children (aged 7-18) with >=40% total body surface area burns.
  • Participants received either GH (0.05 mg/kg/day) or a saline placebo for 12 months.
  • Pulmonary function tests were assessed at baseline and 1 year post-burn.

Main Results:

  • Both GH and placebo groups showed significant increases in PF over 1 year.
  • No statistically significant differences in PF improvement were observed between the GH and placebo groups.
  • Height and weight remained comparable between groups at 12 months post-burn.

Conclusions:

  • GH administration for up to one year demonstrated limited efficacy in improving pulmonary function in burned children.
  • The study suggests that GH therapy may not be a beneficial intervention for enhancing lung function recovery in this population.